STAT3 and cancer: In the present study, GO-Y031 targeted both β-catenin and STAT3, which are transcriptional regulators that control various downstream molecules, such as c-Myc, cyclin D1, vascular endothelial growth factor, and survivine, and contribute to cancer cell growth and survival [37, 38].